Targeted Chemotherapy, Crizotinib, or Placebo in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer after surgery
Can targeted chemotherapy, Crizotinib, stop the growth of tumor cells by blocking the a protein from working?
ALK Gene Rearrangement ALK Gene Translocation ALK Positive Stage IB Non-Small Cell Lung Carcinoma AJCC v7 Stage II Non-Small Cell Lung Cancer AJCC v7 Stage IIA Non-Small Cell Lung Carcinoma AJCC v7 Stage IIB Non-Small Cell Lung Carcinoma AJCC v7 Stage IIIA Non-Small Cell Lung Cancer AJCC v7 Carcinoma Lung Neoplasms Carcinoma, Non-Small-Cell Lung Crizotinib Clinical Observation Laboratory Biomarker Analysis
Lead Scientists at UC Health
- Lyudmila A. Bazhenova (ucsd)
Dr. Bazhenova’s clinical practice and research concentrate on lung cancer, particularly as this relates to females and non-smokers. She actively participates in cooperative group trials, and takes an active role in designing and implementing clinical investigations, including phase II studies and correlative science projects with several UCSD investigators.
- Tianhong Li (ucdavis)
Associate Professor, Hematology and Oncology
- accepting new patients
- Start Date
- ECOG-ACRIN Cancer Research Group
- Phase 3
- Study Type
- Last Updated